|
|
 |
|
Viewing report
|
|
|
|
Baxter International Inc. (BAX) - Product Pipeline Analysis
GlobalData, May 2011, Pages: 42
Baxter International Inc. (BAX) - Product Pipeline Analysis
Summary
Baxter International Inc. (Baxter) is a globally diversified healthcare company. It is engaged in the development, manufacture and marketing of medical products, which save and sustain the lives of people. The company's products assist healthcare professionals and their patients in the treatment of complex medical conditions such as hemophilia, immune disorders, kidney disease, trauma and other conditions. Baxter manufactures its products in 27 countries worldwide. The company markets its products through its own sales force as well as through a network of independent distributors and drug wholesalers in more than 100 countries worldwide. Baxter is headquartered in Illinois, the US.
This report is a source for data, analysis and actionable intelligence on the Baxter International Inc. portfolio of pipeline products. The report provides detailed analysis on each pipeline product with information on the indication, the development stage, trial phase, product milestones, pipeline territory, estimated approval date, and estimated launch date.
Each pipeline product is profiled to cover information on product description, function, technology, indication, and application. The report is also supplemented with a detailed company profile and information on clinical trials, wherever applicable.
This report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by Our team of industry experts.
Scope
- Detailed company profile with information on business description, key company facts, major products and services, key competitors, key employees, locations and subsidiaries and recent developments.
- Detailed coverage on all the pipeline products, by equipment type, by therapy area, by development stage, and by trial phase.
- Information on product milestones and pipeline territory for each product, the estimated approval date, and estimated launch date.
- Profile of each pipeline product with additional information on product description, function, technology, indication(s), and application.
- Data on relevant clinical trials and product patent details, wherever applicable.
- Information on clinical trial, wherever applicable, is supplemented with information on trial phase, trial status, trial objective, trial design, target patients, unique physician identifier, primary point, secondary point, acronym, participants inclusion, participants exclusion, interventions, trial results, trial start date, trial end date, study type, trial site, trial funding, age eligibility, and gender eligibility.
Reasons to Buy
- Develop business strategies by understanding the trends and developments driving the medical devices pipeline and technology landscape globally.
- Design and develop your product development, marketing and sales strategies.
- Exploit M&A opportunities by identifying market players with the most innovative pipeline.
- Develop market-entry and market expansion strategies.
- Exploit in-licensing and out-licensing opportunities by identifying products, most likely to ensure a robust return.
- Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage.
- Develop competition strategies by identifying the status and likely launch of your competitors’ pipeline products through review of the clinical trials, stage and phase of development, etc.
- Which are the next high-value products that your competitor would add in its portfolio? – identify, understand and capitalize.
Customers who bought this item also bought
Kuros Biosurgery AG - Product Pipeline Analysis
Xcorporeal, Inc. (XCRP) - Product Pipeline Analysis
Cytomedix, Inc. (CMXI) - Product Pipeline Analysis
Neogenix Oncology, Inc. - Product Pipeline Analysis
Cohera Medical, Inc. - Product Pipeline Analysis
AcelRx Pharmaceuticals, Inc. (ACRX) - Product Pipeline Analysis
Miraculins Inc. (MOM) - Product Pipeline Analysis
Baxter International Inc. - Product Pipeline Review - Q1 2011
Noveko International Inc. (EKO) - Product Pipeline Analysis
Pioneer Surgical Technology, Inc. - Product Pipeline Analysis
|
|
|
|
